Search

Author/Creator Guillemet, C.

1. 1475PDA randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide and cisplatin (API), followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). Update at 10 years. (18th September 2017)

Authors:
Pautier, P.; Brard, C.; Floquet, A.; Gladieff, L.; Rios, M.; Piperno-Neumann, S.; Berton-Rigaud, D.; Blay, J-Y.; Fabbro, M.; Lotz, J-P.; Vinceneux, A.; Bertucci, F.; De La Motte Rouge, T.; Guillemet, C.; Genestie, C.; Duffaud, F.
Journal:
Annals of oncology
Issue:
Volume 28(2017)Supplement 5
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A phase II of gemcitabine combined with pazopanib followed by pazopanib maintenance, as second-line treatment in patients with advanced leiomyosarcomas: A unicancer French Sarcoma Group study (LMS03 study). (January 2020)

Authors:
Pautier, P.; Penel, N.; Ray-Coquard, I.; Italiano, A.; Bompas, E.; Delcambre, C.; Bay, J.-O.; Bertucci, F.; Delaye, J.; Chevreau, C.; Cupissol, D.; Bozec, L.; Eymard, J.-C.; Saada, E.; Isambert, N.; Guillemet, C.; Rios, M.; Piperno-Neumann, S.; Chenuc, G.; Duffaud, F.
Journal:
European journal of cancer
Issue:
Volume 125(2020)
Page Start:
31
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search